(331) - Cytomegalovirus Viraemia in Intermediate-Risk Heart Transplant Recipients: A 5-Year Comparison of Universal Prophylaxis and Pre-Emptive Therapy. - Lim, R.; Carlos, L.; Burrows, F.; Offen, S.; Chiu, D.; Eckford, H.; Marriott, D.; Wong, N.; Barua, S.; Campos Deveza e Silva, R.; Bart, N.; Jabbour, A.; et al. (Journal of Heart & Lung Transplantation, 2026)